• CloudMD (DOC) to participate in upcoming Laurentian Bank and Bloom Burton & Co. investor conferences
  • The Laurentian Bank Securities Annual Institutional Investor Conference will take place from April 6 to 9, 2021
  • Bloom Burton & Co. Annual Healthcare Investor Conference will take place from April 20 to 21, 2021
  • CloudMD is digitizing the delivery of healthcare by providing a patient-centric approach
  • CloudMD Software & Services Inc. (DOC) is up 1.86 per cent and is trading at C$1.92 at 3:02 pm ET

CloudMD Software & Services Inc. (DOC) has been invited to participate in the upcoming Laurentian Bank Securities and Bloom Burton & Co. investor conferences.

The Laurentian Bank Securities Annual Institutional Investor Conference will take place from April 6 to 9, 2021.

On Thursday, April 8, 2021, at 12:45 pm ET, Diversified Technology Track’s topic will be discussed.

Dr. Essam Hamza will participate in a panel discussion titled, Digital Healthcare: Where To From Here?

Members of management will also be participating in one-on-one investor meetings.

Investors should contact a Laurentian Bank Securities representative for more information and to schedule one-on-one meetings with management.

The Bloom Burton & Co. Annual Healthcare Investor Conference will take place from April 20 to 21, 2021.

Dr. Essam Hamza will be presenting CloudMD and providing an update on the business via a webinar. Members of management will also be participating in one-on-one investor meetings during the conference.

CloudMD is digitizing healthcare delivery by providing a patient-centric approach, with an emphasis on continuity of care.

By leveraging healthcare technology, CloudMD is building one connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. 

CloudMD Software & Services Inc. (DOC) is up 1.86 per cent and is trading at C$1.92 at 3:02 pm ET.

More From The Market Online

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.